Literature DB >> 29683789

DNA Repair Deficiency and Immunotherapy Response.

Kent W Mouw1, Alan D D'Andrea1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29683789     DOI： 10.1200/JCO.2018.78.2425

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

Review 1.  Biomarker-Guided Development of DNA Repair Inhibitors.

Authors:  James M Cleary; Andrew J Aguirre; Geoffrey I Shapiro; Alan D D'Andrea
Journal:  Mol Cell       Date:  2020-05-26       Impact factor: 17.970

Review 2.  Updates on the Genetics and Molecular Subtypes of Urothelial Carcinoma and Select Variants.

Authors:  Hikmat Al-Ahmadie; Gopa Iyer
Journal:  Surg Pathol Clin       Date:  2018-10-17

3.  Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.

Authors:  Lulu Wang; Lin Yang; Chen Wang; Wei Zhao; Zhenlin Ju; Wei Zhang; Jianfeng Shen; Yang Peng; Clemens An; Yen T Luu; Shumei Song; Timothy A Yap; Jaffer A Ajani; Gordon B Mills; Xuetong Shen; Guang Peng
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

4.  Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy.

Authors:  Fei Kuang; Juan Du; Mengjia Zhou; Fangyi Peng; Yu Gan; Cheng Fang; Xiaoli Yang; Bo Li; Song Su
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

5.  Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers.

Authors:  Michael Cerniglia; Joanne Xiu; Axel Grothey; Michael J Pishvaian; Yasmine Baca; Jimmy J Hwang; John L Marshall; Ari M VanderWalde; Anthony F Shields; Heinz-Josef Lenz; W Michael Korn; Mohamed Salem; Philip A Philip; Richard M Goldberg; Jia Zeng; Sunnie S Kim
Journal:  Mol Cancer Ther       Date:  2021-11-01       Impact factor: 6.009

6.  Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer.

Authors:  Matthew P Humphries; Sean Hynes; Victoria Bingham; Delphine Cougot; Jacqueline James; Farah Patel-Socha; Eileen E Parkes; Jaine K Blayney; Michael A O'Rorke; Gareth W Irwin; Darragh G McArt; Richard D Kennedy; Paul B Mullan; Stephen McQuaid; Manuel Salto-Tellez; Niamh E Buckley
Journal:  J Oncol       Date:  2018-12-17       Impact factor: 4.375

Review 7.  Regulation of programmed death-ligand 1 expression in response to DNA damage in cancer cells: Implications for precision medicine.

Authors:  Hiro Sato; Penny A Jeggo; Atsushi Shibata
Journal:  Cancer Sci       Date:  2019-10-04       Impact factor: 6.716

8.  Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer.

Authors:  Reham Abdel-Wahab; Timothy A Yap; Russell Madison; Shubham Pant; Matthew Cooke; Kai Wang; Haitao Zhao; Tanios Bekaii-Saab; Elif Karatas; Lawrence N Kwong; Funda Meric-Bernstam; Mitesh Borad; Milind Javle
Journal:  Sci Rep       Date:  2020-12-16       Impact factor: 4.379

9.  Enhanced Antitumor Response to Immune Checkpoint Blockade Exerted by Cisplatin-Induced Mutagenesis in a Murine Melanoma Model.

Authors:  Falih M Gorgun; Steven G Widen; Douglas S Tyler; Ella W Englander
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

Review 10.  Molecular Pathology of Urothelial Carcinoma.

Authors:  Hikmat Al-Ahmadie; George J Netto
Journal:  Surg Pathol Clin       Date:  2021-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.